1. Tyler VE, ed. The Honest Herbal, 3rd edition. Binghamton: Pharmaceutical Products Press, 1993.

2. Anonymous. Ginkgo. In: The Review of Natural Products. St. Louis: Facts and Comparisons, 1998.

3. Amri H, Ogwuegbu SO, Boujrad N, Drieu K, Papadopoulos V. In vivo regulation of peripheral type benzodiazepine receptor and glucocorticoid synthesis by Ginkgo Biloba extract EGb 761 and isolated ginkgolides. Endocrinology 1996;137:5707-5718.

4. Hasenohrl RU, Nichau CH, Frisch CH, et al. Anxiolytic-like effect of combined extracts of Zingiber officinale and Ginkgo biloba in the elevated plus-maze. Pharmacol Biochem Behav 1996;53:271-275.

5. Nemecz G, Combest WL. Ginkgo biloba. US Pharm 1997;144:147-148, 151.

6. Ramassamy C, Clostre F, Christen Y, Costentin J. Prevention by a ginkgo extract (GBE 761) of the dopaminergic neurotoxicity of MPTP. J Pharm Pharmacol 1990;42:785-789.

7. Houghton P. Ginkgo. Pharm J 1994;253:122-123.

8. Le Bars PL, Katz MM, Berman N, et al. A placebo controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. JAMA 1997;278:1327-1332.

9. Oken BS, Storzbach DM, Kaye JA. The efficacy of Ginkgo biloba on cognitive function in Alzheimer's disease. Arch Neurol 1998;55:1409-1415.

10. van Dongen M, van Rossum E, Kessels A, Sielhorst H, Knipschild P. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial. J Epidemiol 2003;56:367-376.

11. van Dongen M, van Rossum E, Kessels AGH, Sielhorst HJG, Knipschild PG. The efficacy of Ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial. J Am Geriatr Soc 2000;48:1183-1194.

12. Mattes RD, Pawlik MK. Effects of Ginkgo biloba on alertness and chemosensory function in healthy adults. Hum Psychopharmacol Clin Exp 2004;19:81-90.

13. Mix JA, Crews WD Jr. An examination of the efficacy of Ginkgo biloba extract EGb 761 on the neuropsychologic functioning of cognitively intact older adults. J Altern Complement Med 2000;6(3):219-229.

14. Allain H, Raoul P, Lieury A, LeCoz F, Gandon J. Effect of two doses of Ginkgo biloba extract (EGb 761) on the dual-coding test in elderly subjects. Clin Ther 1993;15:549-557.

15. Mix JA, Crews WD. A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761® in a sample of cognitively intact older adults: neuropsychological findings. Hum Psychopharmacol Clin Exp 2002;17:267-277.

16. Kennedy DO, Scholey AB, Wesnes KA. The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers. Psychopharma-cology 2000;151:416-423.

17. Hartley DE, Heinze L, Elsabagh S, File SE. Effects on cognition and mood in postmenopausal women of 1-week treatment with Ginkgo biloba. Pharmacol Biochem Behav 2003;75:711-720.

18. Kanowski S, Hoerr R. Ginkgo biloba extract EGb 761® in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial. Pharmacopsychiatry 2003;36:297-303.

19. Kleijnen J, Knipschild P. Ginkgo biloba. Lancet 1992;340:1136-1139.

20. Rejali D, Sivakumar A, Balaji N. Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clin Otolaryngol 2004;29:226-231.

21. Issing W, Klein P, Weiser M. The homeopathic preparation Vertigoheel® versus Ginkgo biloba in the treatment of vertigo in an elderly population: a double-blinded, randomized, controlled clinical trial. J Altern Complement Med 2005;11(1):155-160.

22. Chow T, Browne V, Heileson HL, Wallace D, Anholm J, Green SM. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness. Arch Intern Med 2005;165:296-301.

23. Gertsch JH, Basnyat B, Johnson EW, Onopa J, Holck PS, on behalf of the Prevention of High Altitude Illness Trial Research Group. Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT). Br Med J 2004;328:797-801.

24. Burschka MA, Abdel-Hady Hassan H, Reineke T, van Bebber L, Caird DM, Mosges R. Effect of treatment with Ginkgo biloba extract EGb 761 (oral) on unilateral idiopathic sudden hearing loss in a prospective randomized double-blind study of 106 outpatients. Eur Arch Otorhinolaryngol 2001;258:213-219.

25. Reisseer C, Weidauer H. Ginkgo biloba extract EGb 761® or pentoxifylline for the treatment of sudden deafness: a randomized, reference-controlled, double-blind study. Acta Otolaryngol 2001;121:579-584.

26. Jung F, Mroweitz C, Kiesewetter H, Wenzel E. Effect of Ginkgo biloba on fluidity of blood and peripheral microcirculation in volunteers. Arzneim Forsch 1990;40:589-593.

27. Huang SY, Jeng C, Kao SC, Yu, JJH, Liu DZ. Improved haemorrheological properties by Gingko biloba extract (Egb 761) in type 2 diabetes mellitus complicated with retinopathy. Clin Nutr 2004;23:615-621.

28. Muir AH, Robb R, McLaren M, Daly F, Belch JJF. The use of Ginkgo biloba in Raynaud's disease: a double-blind placebo-controlled trial. Vasc Med 2002;7:265-267.

29. Mehlsen J, Drabaek H, Wiinberg N, Winther K. Effects of a Gingko biloba extract on forearm haemodynamics in healthy volunteers. Clin Physiol Funct Imaging 2002;22:375-378.

30. Jezova D, Duncko R, Lassanova M, Kriska M, Moncek F. Reduction of rise in blood pressure and cortisol release during stress by Ginkgo biloba extract (EBg 761) in healthy volunteers. J Physiol Pharmacol 2002;53:337-348.

31. Chavez ML, Chavez PI. Ginkgo (Part I): History, use, and pharmacologic properties. Hosp Pharm 1998;33:658-672.

32. Sollier CBD, Caplain H, Drouet L. No alteration in platelet function or coagulation induced by EGb761 in a controlled study. Clin Lab Haem 2003;25:251-253.

33. Kohler S, Funk P, Kieser M. Influence of a 7-day treatment with Ginkgo biloba special extract EGb 761 on bleeding time and coagulation: a randomized, placebo-controlled, double-blind study in healthy volunteers. Blood Coagul Fibrinolysis 2004;15:303-309.

34. Kim SH, Lee EK, Chang JW, Min WK, Chi HS, Kim SB. Effectsw of Ginkgo biloba on haemostatic factors and inflammation in chronic peritoneal dialysis patients. Phytother Res 2005;19:546-548.

35. Kudolo GB, Dorsey S, Blodgett J. Effect of the ingestion of Ginkgo biloba extract on platelet aggregation and urinary prostanoid excretion in healthy and Type 2 diabetic subjects. Thromb Res 2003;108:151-160.

36. Blumenthal M, ed. Ginkgo biloba. The complete German commission E monographs. Austin: American Botanical Council, 1998.

37. Kudolo GB. The effect of 3-month ingestion of Ginkgo biloba extract on pancreatic ß-cell function in response to glucose loading in normal glucose tolerant individuals. J Clin Pharmacol 2000;40:647-654.

38. Kudolo GB. The effect of 3-month ingestion of Ginkgo biloba extract (EGb 761) on pancreatic ß-cell function in response to glucose loading in individuals with non-insulin-dependent diabetes mellitus. J Clin Pharmacol 2001;41:600-611.

39. Kang BJ, Lee SJ, Kim MD, Cho MJ. A placebo-controlled, double-blind trial of Ginkgo biloba for anti depressant-induced sexual dysfunction. Hum Psychopharmacol Clin Exp 2002;17:279-284.

40. Wheatley D. Triple-blind, placebo-controlled trial of Ginkgo biloba in sexual dysfunction due to antidepressant drugs. Hum Psychopharmacol Clin Exp 2004;19:545-548.

41. Chung KF, McCusker M, Page CP, Dent G, Guinot P, Barnes PJ. Effect of ginkgolide mixture (BN 52063) in antagonizing skin and platelet responses to platelet activating factor in man. Lancet 1987;1:248-251.

42. Kim YS, Pyo MK, Park PH, Hahn BS, Wu SJ, Yun-Choi HS. Antiplatelet and antithrombotic effects of a combination of ticlopidine and Ginkgo biloba extract (EGb 761). Thrombos Res 1998;91:33-38.

43. Jiang X, Williams K, Liauw W, et al. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Brit J Clin Pharmacol 2005;59(4):425-432.

44. Engelsen J, Nielsen JD, Winthere K. Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in stable, long-term warfarin treated outpatients. A randomized, double-blind, placebo-crossover trial. Thromb Haemost 2002;87:1075-1076.

45. Yale SH, Glurich I. Analysis of the inhibitory potential of Ginkgo biloba,Echinacea purpurea, and Serenoa repens on the metabolic activity of cytochrome P450 3A4, 2D6, and 2C9.

46. von Moltke LL, Weemhoff JL, Bedir E, et al. Inhibition of human cytochromes P450 by components of Ginkgo biloba. J Plant Pathol 2004;56:1039-1044.

47. He N, Edeki T. The inhibitory effects of herbal components on CYP2C9 and and CYP3A4 catalytic activities in human liver microsomes. Am J Therapeutics 2004;11:206-212.

48. Markowitz JS, Donovan JL, DeVane CL, Sipkes L, Chavin KD. Multiple-dose administration of Ginkgo biloba did not affect cytochrome P-450 2D6 or 3A4 activity in normal volunteers. J Clin Psychopharmacol 2003;23:576-581.

49. Yin OQP, Tomlinson B, Waye MMY, Chow AHL, Chow MSS. Pharmacokinetics and herb-drug interactions: experience with Ginkgo biloba and omeprazole. Pharmacogenetics 2004;14:841-850.

50. Yasui-Furukori N, Furukori H, Kaneda A, Kaneko S, Tateishi T. The effects of Ginkgo biloba extracts on the pharmacokinetics and pharmacodynamics of donepezil. J Clin Pharmacol 2004;44:538-542.

51. Duche JC, Barre J, Guinot P, Duchier J, Cournot A, Tillement JP. Effect of Ginkgo biloba extract on microsomal enzyme induction. Int J Clin Pharmacol Res 1989;9:165-168.

52. Fourtillan JB, Brisson AM, Girault J, et al. Pharmacokinetic properties of bilobalide and ginkgolides A and B in healthy subjects after intravenous and oral administration of Ginkgo biloba extract (EGb 761). Therapie 1995;50:137-144.

53. Pietta PG, Gardana C, Mauri PL. Identification of Ginkgo flavonol metabolites after oral administration to humans. J Chromatogr Biomed Sci Appl 1997;693:249-255.

54. Gilbert GJ. Ginkgo biloba [letter]. Neurology 1997;48:1137.

55. Rowin J, Lewis SL. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion [letter]. Neurology 1996;46:1775-1776.

56. Vale S. Subarachnoid hemorrhage associated with Ginkgo biloba [letter]. Lancet 1998;352:36.

57. Matthews MK. Association of Ginkgo biloba with intracranial hemorrhage [letter]. Neurology 1998;50:1933-1934.

58. Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract [letter]. N Engl J Med 1997;336:1108.

59. Yagmur E, Piatkowski A, Groger A, Pallua N, Gressner AM, Kiefer P. Bleeding complication under Gingko biloba medication. Letter to the Editor. Am J Hematol 2005;79:343-345.

60. Bebbington A, Kulkarni R, Roberts P. Ginkgo biloba. Persistent bleeding after total hip arthroplasty caused by herbal self-medication. J Arthroplasty 2005;20(1):125-126.

61. Arenz A, Klein M, Fiehe K, et al. Occurrence of neurotoxic 4'-O-mehtylpyridoxine in Ginkgo biloba leaves, Ginkgo medications, and Japanese ginkgo food. Planta Med 1996;62:548-551.

Do Not Panic

Do Not Panic

This guide Don't Panic has tips and additional information on what you should do when you are experiencing an anxiety or panic attack. With so much going on in the world today with taking care of your family, working full time, dealing with office politics and other things, you could experience a serious meltdown. All of these things could at one point cause you to stress out and snap.

Get My Free Ebook

Post a comment